Molecular imaging targeting peptide receptors.

Area of Science:

• Nuclear medicine
• Radiopharmaceutical chemistry
• Molecular imaging

Background:

• Overexpressed neuropeptide receptors on tumors enable molecular imaging.
• Radiolabeled peptidic ligands are used for positron emission tomography (PET) and single photon emission computed tomography (SPECT).

Purpose of the Study:

• To review the development of radiolabeled probes for peptide receptor imaging.
• To focus on peptide radiopharmaceuticals developed in the last five years.
• To highlight key factors in tracer development and evaluation.

Main Methods:

• Literature review of radiolabeled probes for peptide receptor imaging.
• Focus on advancements in peptide radiopharmaceuticals.
• Analysis of critical factors in tracer development.

Main Results:

• Summary of historical and recent developments in peptide receptor imaging agents.
• Identification of crucial elements influencing the success of radiotracer development.
• Overview of current trends and future directions in the field.

Conclusions:

• Peptide receptor imaging is a valuable tool for tumor visualization.
• Continued development of novel peptide radiopharmaceuticals is essential.
• Understanding tracer development factors optimizes clinical application.